Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 260

1.

Single-Molecule Co-Immunoprecipitation Reveals Functional Inheritance of EGFRs in Extracellular Vesicles.

Sung MS, Jung JH, Jeong C, Yoon TY, Park JH.

Small. 2018 Sep 21:e1802358. doi: 10.1002/smll.201802358. [Epub ahead of print]

PMID:
30239124
2.

Macrophagic Stabilin-1 Restored Disruption of Vascular Integrity Caused by Sepsis.

Lee W, Park SY, Yoo Y, Kim SY, Kim JE, Kim SW, Seo YK, Park EK, Kim IS, Bae JS.

Thromb Haemost. 2018 Sep 20. doi: 10.1055/s-0038-1669477. [Epub ahead of print]

PMID:
30235477
3.

Self-Triggered Apoptosis Enzyme Prodrug Therapy (STAEPT): Enhancing Targeted Therapies via Recurrent Bystander Killing Effect by Exploiting Caspase-Cleavable Linker.

Chung SW, Choi JU, Cho YS, Kim HR, Won TH, Dimitrion P, Jeon OC, Kim SW, Kim IS, Kim SY, Byun Y.

Adv Sci (Weinh). 2018 Jun 5;5(7):1800368. doi: 10.1002/advs.201800368. eCollection 2018 Jul.

4.

Designed trimer-mimetic TNF superfamily ligands on self-assembling nanocages.

Kih M, Lee EJ, Lee NK, Kim YK, Lee KE, Jeong C, Yang Y, Kim DH, Kim IS.

Biomaterials. 2018 Oct;180:67-77. doi: 10.1016/j.biomaterials.2018.07.009. Epub 2018 Jul 7.

PMID:
30025246
5.

Direct observation of DNA target searching and cleavage by CRISPR-Cas12a.

Jeon Y, Choi YH, Jang Y, Yu J, Goo J, Lee G, Jeong YK, Lee SH, Kim IS, Kim JS, Jeong C, Lee S, Bae S.

Nat Commun. 2018 Jul 17;9(1):2777. doi: 10.1038/s41467-018-05245-x.

6.

Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer.

Nam GH, Lee EJ, Kim YK, Hong Y, Choi Y, Ryu MJ, Woo J, Cho Y, Ahn DJ, Yang Y, Kwon IC, Park SY, Kim IS.

Nat Commun. 2018 Jun 4;9(1):2165. doi: 10.1038/s41467-018-04607-9.

7.

Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein Receptor-Derived Peptides for Regulation of Mast Cell Degranulation.

Yang Y, Kong B, Jung Y, Park JB, Oh JM, Hwang J, Cho JY, Kweon DH.

Front Immunol. 2018 Apr 11;9:725. doi: 10.3389/fimmu.2018.00725. eCollection 2018.

8.

Comparison of exosomes and ferritin protein nanocages for the delivery of membrane protein therapeutics.

Cho E, Nam GH, Hong Y, Kim YK, Kim DH, Yang Y, Kim IS.

J Control Release. 2018 Jun 10;279:326-335. doi: 10.1016/j.jconrel.2018.04.037. Epub 2018 Apr 19.

PMID:
29679665
9.

Engineering nanoparticle strategies for effective cancer immunotherapy.

Yoon HY, Selvan ST, Yang Y, Kim MJ, Yi DK, Kwon IC, Kim K.

Biomaterials. 2018 Sep;178:597-607. doi: 10.1016/j.biomaterials.2018.03.036. Epub 2018 Mar 21.

PMID:
29576282
10.

Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery.

Yang Y, Hong Y, Cho E, Kim GB, Kim IS.

J Extracell Vesicles. 2018 Mar 1;7(1):1440131. doi: 10.1080/20013078.2018.1440131. eCollection 2018. Review.

11.

Nanocage-Therapeutics Prevailing Phagocytosis and Immunogenic Cell Death Awakens Immunity against Cancer.

Lee EJ, Nam GH, Lee NK, Kih M, Koh E, Kim YK, Hong Y, Kim S, Park SY, Jeong C, Yang Y, Kim IS.

Adv Mater. 2018 Mar;30(10). doi: 10.1002/adma.201705581. Epub 2018 Jan 15.

PMID:
29333661
12.

A targeted ferritin-microplasmin based thrombolytic nanocage selectively dissolves blood clots.

Seo J, Al-Hilal TA, Jee JG, Kim YL, Kim HJ, Lee BH, Kim S, Kim IS.

Nanomedicine. 2018 Apr;14(3):633-642. doi: 10.1016/j.nano.2017.12.022. Epub 2018 Jan 6.

PMID:
29309907
13.

Comparison of in vivo targeting ability between cRGD and collagen-targeting peptide conjugated nano-carriers for atherosclerosis.

Kim M, Sahu A, Kim GB, Nam GH, Um W, Shin SJ, Jeong YY, Kim IS, Kim K, Kwon IC, Tae G.

J Control Release. 2018 Jan 10;269:337-346. doi: 10.1016/j.jconrel.2017.11.033. Epub 2017 Nov 22.

PMID:
29175140
14.

Programmed Cell Death Protein Ligand-1 Silencing with Polyethylenimine-Dermatan Sulfate Complex for Dual Inhibition of Melanoma Growth.

Kwak G, Kim D, Nam GH, Wang SY, Kim IS, Kim SH, Kwon IC, Yeo Y.

ACS Nano. 2017 Oct 24;11(10):10135-10146. doi: 10.1021/acsnano.7b04717. Epub 2017 Oct 12.

15.

Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting.

Kim SM, Yang Y, Oh SJ, Hong Y, Seo M, Jang M.

J Control Release. 2017 Nov 28;266:8-16. doi: 10.1016/j.jconrel.2017.09.013. Epub 2017 Sep 12.

PMID:
28916446
16.

Xk-related protein 8 regulates myoblast differentiation and survival.

Kim GW, Nam GH, Kim IS, Park SY.

FEBS J. 2017 Nov;284(21):3575-3588. doi: 10.1111/febs.14261. Epub 2017 Sep 28.

PMID:
28881496
17.

Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics.

Lee NK, Lee EJ, Kim S, Nam GH, Kih M, Hong Y, Jeong C, Yang Y, Byun Y, Kim IS.

J Control Release. 2017 Dec 10;267:172-180. doi: 10.1016/j.jconrel.2017.08.014. Epub 2017 Aug 15.

PMID:
28821462
18.

Radiotherapy-assisted tumor selective metronomic oral chemotherapy.

Chung SW, Kweon S, Lee BS, Kim GC, Mahmud F, Lee H, Cho YS, Choi JU, Jeon OC, Kim JW, Kim SW, Kim IS, Kim SY, Byun Y.

Int J Cancer. 2017 Nov 1;141(9):1912-1920. doi: 10.1002/ijc.30842. Epub 2017 Aug 2.

PMID:
28635011
19.

Engulfment signals and the phagocytic machinery for apoptotic cell clearance.

Park SY, Kim IS.

Exp Mol Med. 2017 May 12;49(5):e331. doi: 10.1038/emm.2017.52. Review.

20.

Assembly of polymer micelles through the sol-gel transition for effective cancer therapy.

Khaliq NU, Oh KS, Sandra FC, Joo Y, Lee J, Byun Y, Kim IS, Kwon IC, Seo JH, Kim SY, Yuk SH.

J Control Release. 2017 Jun 10;255:258-269. doi: 10.1016/j.jconrel.2017.04.039. Epub 2017 Apr 26.

PMID:
28456679

Supplemental Content

Loading ...
Support Center